BrainsWay to Present at the 2019 Raymond James Life Sciences and MedTech Conference

Home/Client News/BrainsWay to Present at the 2019 Raymond James Life Sciences and MedTech Conference

BrainsWay to Present at the 2019 Raymond James Life Sciences and MedTech Conference

JERUSALEM and HACKENSACK, N.J., June 13, 2019 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE:BWAY) (BrainsWay” or the “Company”), a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation system (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), today announced that Yaacov Michlin, Chief Executive Officer, will participate at the upcoming Raymond James Life Sciences and MedTech Conference being held on June 18-19, 2019 at the Lotte New York Palace, NY.

By | 2019-06-13T15:19:28+00:00 June 13th, 2019|Client News|Comments Off on BrainsWay to Present at the 2019 Raymond James Life Sciences and MedTech Conference